secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jasper Therapeutics, Inc. (JSPR)
CIK:        0001788028
Form:       8-K
Filed at:   2025-07-03T23:59:59+00:00
Accession:  0001213900-25-061471
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Jasper Therapeutics shareholders elect directors, ratify PwC, approve say-on-pay
--------------------------------------------------------------------------------

- Elected Kurt von Emster, Scott Brun, and Vishal Kapoor as Class I directors with >8.4M votes each.
- Ratified PwC as independent auditor for FY 2025: 11,992,658 for, 18,646 against.
- Advisory say-on-pay approved: 8,108,299 for, 536,022 against, 9,718 abstentions.
- Advisory vote on frequency favored every 1 year (8,580,886 votes); company will hold annual say-on-pay votes.
- Turnout ~80% (12,014,527 of 15,022,122 shares represented).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1788028/000121390025061471/0001213900-25-061471-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1788028/000121390025061471/ea0248135-8k_jasper.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-061471

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer